Macrogenics reported $352.9M in Market Capitalization this January of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US USD 237.3B 33.36B
Amgen AMGN:US USD 120.36B 9.61B
AstraZeneca AZN:LN USD 154.08B 13.26B
Biogen BIIB:US USD 39.1B 9.24B
Bristol Myers Squibb BMY:US USD 151.8B 12.14B
Daiichi Sankyo 4568:JP JPY 8.16T 286.78B
Eli Lilly And LLY:US USD 307.24B 831M
Genmab GEN:DC DKK 162.01B 10.97B
Geron GERN:US USD 884M 299M
Gilead Sciences GILD:US USD 77.36B 170M
Immunogen IMGN:US USD 1.06B 63M
Johnson & Johnson JNJ:US USD 461.85B 32.35B
Karyopharm Therapeutics KPTI:US USD 442M 82M
Macrogenics MGNX:US USD 213M 32M
Merk MRK:US USD 218.17B 12.39B
Mirati Therapeutics MRTX:US USD 3.88B 156M
Pfizer PFE:US USD 245.6B 48.58B
Puma Biotechnology PBYI:US USD 108M 20M
Regeneron Pharmaceuticals REGN:US USD 75.09B 10.16B
Roche Holding ROG:VX CHF 263.11B 68.64B
Seattle Genetics SGEN:US USD 25.24B 7.33B
Xencor XNCR:US USD 1.55B 79M